The ongoing European randomised trial of screening for prostate cancer (ERSPC) involves centres in eight countries.
It is one of only two randomised trials worldwide examining the effect of routine screening by PSA testing on mortality from prostate cancer, and has recruited over 160,000 men in the core age-group, 55-69 at entry.
The central database for this study is held in the Centre for Cancer Prevention; data are obtained from all centres at regular intervals, and analyses and reports produced for the Data Monitoring and Scientific Committees.
- Professor Sue Moss
- Mary Neville
Phone: +44 (0) 20 7882 3493